ClinVar Miner

Submissions for variant NM_024740.2(ALG9):c.1173+2T>A

dbSNP: rs786205134
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Genomic Research Center, Shahid Beheshti University of Medical Sciences RCV000211586 SCV000845291 pathogenic Gillessen-Kaesbach-Nishimura syndrome 2018-08-07 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV003390836 SCV004133296 uncertain significance not provided 2023-02-01 criteria provided, single submitter clinical testing ALG9: PM2, PP3
Clinical Genetics and Genomics, Karolinska University Hospital RCV000170339 SCV000195551 pathogenic Gillessen-Kaesbach-Nishimura dysplasia 2014-11-24 no assertion criteria provided clinical testing We observed a novel phenotype, characterized by skeletal dysplasia and visceral malformations, and propose the name Gilessen-Kaesbach-Nishimura dysplasia for this severe form of congenital disorder glycosylation. Gilessen-Kaesbach-Nishimura dysplasia phenotype is at the most severe end of the CDG1L spectrum (lethal).
OMIM RCV000211586 SCV000268527 pathogenic Gillessen-Kaesbach-Nishimura syndrome 2015-05-13 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.